Logo

Varelas to Distribute Syngene's Image-Analysis Tech in Greece

Jul 14, 2008
NEW YORK (GenomeWeb News) – Image-analysis company Syngene said on Friday that it has tapped Varelas to distribute its products in Greece.
 
Under the agreement, Athens-based in vitro diagnostic distributor Varelas will market Syngene’s1D gel documentation systems, including its U:Genius and the G:Box image-analysis systems, as well as its Dyversity and Dymension systems for 2D gel analysis.
 
Syngene’s divisional manager Laura Sullivan said in a statement that Varelas’ “expertise with life science reagents and equipment” will help the company expand its Greek business.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.